These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 12838290

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B, Schonewille H, van de Watering L, Brand A.
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
    Tormey CA, Fisk J, Stack G.
    Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
    [Abstract] [Full Text] [Related]

  • 6. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis.
    Shukla JS, Chaudhary RK.
    Indian J Pathol Microbiol; 1999 Jul; 42(3):299-302. PubMed ID: 10862287
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning.
    Worel N, Böhm A, Rabitsch W, Leitner G, Mitterbauer M, Kalhs P, Mayr WR, Schwartz D, Greinix HT.
    Transfusion; 2012 Jun; 52(6):1348-53. PubMed ID: 22128859
    [Abstract] [Full Text] [Related]

  • 9. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
    el-Danasoury AS, Eissa DG, Abdo RM, Elalfy MS.
    Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
    Godfrey GJ, Lockwood W, Kong M, Bertolone S, Raj A.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1134-7. PubMed ID: 20979172
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
    Schetelig J, Breitschaft A, Kröger N, Zabelina T, Ebell W, Bornhäuser M, Haack A, Ehninger G, Salama A, Siegert W, Cooperative Transplantations Study Group.
    Transfusion; 2005 May 01; 45(5):779-87. PubMed ID: 15847669
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr 01; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.